High Tide Q2 2026 Financial Results: Record Revenue of $179.3M and Positive Net Income

High Tide Inc. reported strong second quarter 2026 financial results with record revenue of $179.3 million, representing 30% year-over-year growth. The company achieved positive net income of $24,000, a significant improvement from a $2.8 million loss in the prior year. Adjusted EBITDA reached a record $13.9 million, up 73% year-over-year. Key highlights include the company's German medical cannabis subsidiary, Remexian Pharma, generating record revenue of $31.6 million with gross margins increasing to 27%. High Tide secured $40 million in senior secured credit facilities from Bank of Montreal to fuel non-dilutive growth. The company's Canadian Cabana Club membership exceeded 2.65 million, up 39% year-over-year, while ELITE members surpassed 178,000, up 84%. High Tide maintains a leading 12% market share in Canadian cannabis retail across five provinces.